Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Uterine Neoplasms
Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER